BioPharma

As the U.S. production investments continue to roll in 2025, LTS Lohmann, the German pharmaceutical technology specialist, is joining the table with a deal to boost its CDMO firepower in the U.S. Like many other contract manufacturing expansions that have...

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression to phase 2 clinical trials in Malawi. Demonstrates Recipharm’s agility and flexibility, completing full tech transfer, scale-up and process optimisation within three months. Strengthens Recipharm’s position as a trusted partner...

Exploring Novel Excipients for Next Generation Drug Formulation The landscape of pharmaceutical development finds itself at a critical juncture where the complexity of drug molecules increasingly outpaces the capabilities of traditional formulation approaches. Novel excipients drug formulation represents not merely...

Revolutionizing Oral Drug Delivery with Nanotechnology The pharmaceutical landscape stands at a transformative juncture where nanotechnology oral drug delivery systems are reshaping how medications reach their therapeutic targets. This convergence of nanoscience and pharmaceutical formulation addresses fundamental challenges that have...

Thermo Fisher Scientific Inc., the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the...

Biopharmaceutical Formulation Challenges and Stability Solutions The biopharmaceutical revolution has fundamentally transformed therapeutic medicine, with protein-based therapeutics including monoclonal antibodies, fusion proteins, antibody-drug conjugates, and advanced biologic systems becoming cornerstones of treatment for cancer, autoimmune diseases, metabolic disorders, and numerous...

Personalized Medicine and the Future of Precision Formulation The medical landscape witnesses a profound transformation as precision formulation personalized medicine reshapes therapeutic paradigms from population-based approaches toward individually tailored interventions. This evolution represents more than incremental improvement in healthcare delivery;...